Navigating the Healthcare and Life Sciences Market: Dual-Track Process and Exit Considerations
Against the backdrop of an ever-changing capital markets landscape, Cooley’s Market Talks virtual series cuts through the noise and drills down on what you need to know about the current market.
During this installment of Market Talks, our panel of thought leaders will discuss the state of the capital and M&A markets, expected trends for 2024, the dual-track process, and exit considerations for healthcare and life sciences companies.
Topics of discussion:
· Market update and recent events
· Dual-track process
· M&A considerations
· IPO considerations
· A look ahead
In a quickly shifting market, this virtual series arms leaders with clear and topical insights to help guide decision-making.
Presenters
· Benjamin Burdett – Managing director and head of healthcare equity capital markets at J.P. Morgan
· Ben Carpenter – Managing director and co-head of North America M&A at J.P. Morgan
· Div Gupta – Partner at Cooley
· Jamie Leigh – Partner and co-chair of the M&A practice at Cooley
· Dave Peinsipp (moderator) – Partner and co-chair of the capital markets practice at Cooley
12:00 – 12:45 pm PDT
1:00 – 1:45 pm MDT
2:00 – 2:45 pm CDT
3:00 – 3:45 pm EDT
For more information, please email Andrew Gentilucci at agentilucci@cooley.com